Sinyor, Mark; Williams, Marissa; Belo, Sue; Orser, Beverley; Vincent, Margaret; Mah, Linda; Zarate, Carlos; Castel, Saulo; Levitt, Anthony J.; Schaffer, Ayal
(Elsevier, 2018)
Background
Ketamine is known to rapidly reduce depressive symptoms and suicidal ideation (SI) in patients with major depressive disorder (MDD), but evidence is limited for its acceptability and effectiveness in “real-world” ...